North America:
North America holds a significant share of the UTI drugs market, driven by the high incidence of urinary tract infections and the advanced healthcare infrastructure in the region. The United States dominates the market, with increasing cases of antibiotic-resistant infections leading to a higher demand for novel UTI treatments. In Canada, the market is also growing steadily,...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian